Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 25, 2013
Palliative and oncologic co-management: symptom management for outpatients with cancerKara Bischoff, Vivian Weinberg, Michael W Rabow
Asian Pacific Journal of Cancer Prevention : APJCP|August 21, 2008
Longitudinal study of smoking progression in Chinese and Vietnamese American adolescentsCelia P Kaplan, Tung T Nguyen, Vivian Weinberg
The Journal of Urology|May 6, 2004
Practice and progress in kidney cancer: methodology for novel drug developmentBrian I Rini, Vivian Weinberg, Eric J Small
Cancer|December 15, 2006
Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?Mack Roach, Vivian Weinberg, Howard Sandler, et al.
Cancer|December 22, 2004
A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinomaBrian I Rini, Vivian Weinberg, Eric J Small
Clinical Prostate Cancer|October 4, 2005
Prior estrogen therapy as a predictor of response to subsequent estramustine-based chemotherapy in patients with androgen-independent prostate cancerJorge A Garcia, Vivian Weinberg, Eric J Small
World Journal of Gastroenterology|March 14, 2007
Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canalKim Huang, Daphne Haas-Kogan, Vivian Weinberg, et al.
Clinical Prostate Cancer|July 5, 2005
Antigen-presenting cells 8015 (Provenge) in patients with androgen-dependent, biochemically relapsed prostate cancerGarth Beinart, Brian I Rini, Vivian Weinberg, et al.
Brachytherapy|November 10, 2004
Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapyI-Chow J Hsu, Etienne Lessard, Vivian Weinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Prostate-specific antigen kinetics as a measure of the biologic effect of granulocyte-macrophage colony-stimulating factor in patients with serologic progression of prostate cancerBrian I Rini, Vivian Weinberg, Robert Bok, et al.
Pageof 10